首页> 美国卫生研究院文献>Iranian Journal of Pediatrics >Isolation and Identification of E. cowanii from Powdered Infant Formula in NICU and Determination of Antimicrobial Susceptibility of Isolates
【2h】

Isolation and Identification of E. cowanii from Powdered Infant Formula in NICU and Determination of Antimicrobial Susceptibility of Isolates

机译:重症监护病房中婴儿配方奶粉中大肠杆菌的分离和鉴定及其分离物的药敏性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Objective: Enterobacter cowanii is a genus of common gram-negative, facultatively anaerobic, rod-shaped, non-spore-forming bacterium of the Enterobacteriaceae family. This organism can be potentially a powdered infant milk formula-borne opportunistic pathogen. The aim of this study was to isolate and identify E. cowanii from consumed powdered infant formula milk (PIF) in intensive care units (NICU) and to determine antimicrobial susceptibility patterns of this bacterium. >Methods: E. cowanii was isolated according to FDA method in 125 samples of PIF milk purchased from drug stores between Jun 2011 and March 2012. For final confirmation, biochemical tests embedded in API-20E system were used. The drug susceptibility test was performed using the disc diffusion method according to CLSI recommendations. >Findings >: Out of the 125 PIF samples investigated, 4 (3.2%) samples were positive for E. cowanii. All four isolates from PIF samples were uniformly susceptible to imipenem, meropenem, ceftazidime, ciprofloxacin, and colistin. Fifty percent of isolates were resistant to ampicillin, amoxicillin, and cotrimoxazole >Conclusion: Analysis of the results indicated that complementary studies are necessary to clarify the possible role of E. cowanii as a food contaminant, in common NICU infections and high risk groups including persons with underlying disease and immunocompromised individuals.
机译:>目的:牛肠杆菌是肠杆菌科常见的革兰氏阴性,兼性厌氧,杆状,无芽孢的细菌的属。该生物体可能是粉状婴儿配方奶粉中的机会致病菌。这项研究的目的是从重症监护病房(NICU)中从食用的婴儿配方奶粉(PIF)中分离和鉴定大肠埃希菌,并确定该细菌的抗菌药敏感性模式。 >方法:根据FDA的方法,在2011年6月至2012年3月间从药店购买的125种PIF牛奶样品中分离出牛大肠杆菌。为了最终确认,使用了API-20E系统中嵌入的生化测试。药物敏感性试验是根据CLSI建议,使用圆盘扩散法进行的。 >发现 >:在所调查的125个PIF样本中,有4个(3.2%)样本的牛大肠杆菌感染呈阳性。从PIF样品中分离出的所有四个分离株均对亚胺培南,美洛培南,头孢他啶,环丙沙星和大肠粘菌素均敏感。 50%的分离株对氨苄西林,阿莫西林和cotrimoxazole具有抗性。和高危人群,包括患有基础疾病的人和免疫功能低下的人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号